Frederic Boned - 11 Feb 2026 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
SVP/GM, Human Nutri. & Health
Signature
/s/ Travis Larsen, Attorney in Fact for Frederic Boned
Issuer symbol
BCPC
Transactions as of
11 Feb 2026
Net transactions value
-$241,691
Form type
4
Filing time
13 Feb 2026, 18:04:45 UTC
Previous filing
10 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Boned Frederic SVP/GM, Human Nutri. & Health C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE /s/ Travis Larsen, Attorney in Fact for Frederic Boned 13 Feb 2026 0001953220

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Award $0 +2,870 +55% $0.000000 8,085 11 Feb 2026 Direct F1
transaction BCPC Common Stock Award $0 +2,247 +28% $0.000000 10,332 11 Feb 2026 Direct F2
transaction BCPC Common Stock Tax liability $205,661 -1,151 -11% $178.68 9,181 11 Feb 2026 Direct F3
transaction BCPC Common Stock Tax liability $36,030 -203 -2.2% $177.49 8,978 12 Feb 2026 Direct F4
holding BCPC Common Stock 441 11 Feb 2026 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Option Award $0 +10,500 $0.000000 10,500 11 Feb 2026 Common Stock 10,500 $178.68 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2 Represents the vesting of performance stock units (includes 37 dividend equivalent shares) for the 2023-2025 performance period.
F3 1,151 of the 2,247 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4 Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5 Options vest 20% Year 1, 40% Year 2, and 40% Year 3.